About: Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.34 (+0.56%)
UPB NASDAQ Upstream Bio, Inc.
Upstream Bio, Inc. share price
UPB price activity
Last Price
$5.340
Change (24hr)
0.03 USD (0.57%)
Volume
938.83K
Volume (4w avg)
-
Open
$5.32
Day Range
$5.21 - $5.41
Previous Close
$5.31
Last Trade
18 Sep, 8:01 pm GMT+0
Delayed
18 Sep, 8:01 pm GMT+0
UPB price performance
Delayed
18 Sep, 8:01 pm GMT+0
UPB Market Signals